Itoco Inc.

Equities

ITMC

US4657212076

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 11:00:33 2024-04-29 am EDT			5-day change	1st Jan Change
0.005 ^USD	0.00%		0.00%	-26.47%

2023	ITOCO INC. Signs MOU for Indigenous Project in South Africa	CI
2023	Itoco Inc. Signs Agreement with Colorful Euphoria, Lda	CI

Itoco Inc. Announces Change of Address of Its Principal Executive Offices

September 16, 2019 at 09:06 am EDT

Itoco Inc. announced that effective immediately, the Company has changed the address of its principal executive offices to: 880 – 50 West Liberty Street, Reno NV 89501. The mailing address is: 1 - 2857 Sherwood Heights Drive, Oakville ON L6J7J9. Company’s telephone number is: 905-829-5000 and fax number is: 905-829-4144.

Latest news about Itoco Inc.

ITOCO INC. Signs MOU for Indigenous Project in South Africa	23-01-18	CI
Itoco Inc. Signs Agreement with Colorful Euphoria, Lda	23-01-05	CI
ITOCO Welcomes Jose Alves as Chief Agronomist	22-12-20	CI
ITOCO INC. Announces Management Changes	22-12-19	CI
Michael Paul Steps Down as CEO of Itoco Inc	22-12-19	CI
Itoco Inc. acquired 49% stake in Colorful Euphoria, Lda for €5 million.	22-05-09	CI
ITOCO Appoints Maria Teresa Tattersfield Yarza to Board of Directors and Carbon Credit Advisory Board	21-10-21	CI
Itoco Inc. acquired All the Assets of ECAPFIN S.A.P.I. De C.V.	21-03-10	CI
ACGT DNA Technologies Corporation Announces Termination Notice of the Joint Development Agreement with ITOCO, Inc	20-11-09	CI
Itoco Inc. Completes Blockchain Smart Contract for Immutable Virus Test Result Verification System	20-10-01	CI
ACGT DNA Technologies Corporation Announces Joint Development Agreement with ITOCO, Inc	20-07-24	CI
Itoco Inc. Announces Change of Address of Its Principal Executive Offices	19-09-16	CI
Itoco and Mountain Trading SAS Sign JV to Expand CBD Potential in Colombia	19-07-09	CI
Itoco Mining Corp will Change its Name to Itoco Inc	18-05-08	CI
Itoco Mining Corporation will Change its Ticker to ITMC from ITMCD	18-03-07	CI
Itoco Inc. announced that it has received CAD 0.1 million in funding	17-08-01	CI
Itoco Inc. announced that it expects to receive CAD 0.1 million in funding	17-07-24	CI
Itoco Mining Corporation Appoints Stewart A. Jackson to its Advisory Board	17-03-14	CI
Itoco Mining Corporation Hires Jose Ramon Guerrero Santafe as Chief Geologist	16-01-13	CI
Itoco Mining Corp. will Change its Ticker to ITMC from GBTO	15-12-01	CI
Globotek Holdings, Inc. will Change its Name to Itoco Mining Corp	15-12-01	CI

Chart Itoco Inc.

Duration

Period

More charts

Company Profile

Itoco Inc. is engaged in soil rehabilitation, carbon sequestering, and biofuel production for the clean energy sector. It has co-developed climate change related products and technologies and is promoting its soil rescue program in Europe and Africa. It has an organic solution to regenerating arid land on a mass scale. Its technology is creating a solution for the capture, quantification and monetization of Nopal Cactus carbon offsets. It helps the local economy in the Nopal harvest that is being used to create food sources, clean energy, and commodities, such as consumer products and fertilization to support and build local industry. Its Nopal Cactus farms in Portugal are providing the cladodes (paddles) for planting new crops of its cactus in participating countries in Africa. It brings Nopal Cactus to allow local economies to produce food, animal feed, organic fertilizer, industrial carbonates and energy, such as biogas, biodiesel and ethanol to create sustainable communities.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ITOCO INC.	-26.47%	937K
IQVIA HOLDINGS INC.	+1.77%	42.86B
LONZA GROUP AG	+45.43%	41.36B
MODERNA, INC.	+12.24%	42.74B
CELLTRION, INC.	-8.83%	27.68B
ICON PUBLIC LIMITED COMPANY	+7.44%	25.15B
ALNYLAM PHARMACEUTICALS, INC.	-23.01%	18.63B
MEDPACE HOLDINGS, INC.	+30.56%	12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.82%	11.92B
UNITED THERAPEUTICS CORPORATION	+8.35%	11.21B

Other Biotechnology & Medical Research